FENNEC PHARMACEUTICALS INC.

(FENC)
  Rapport
Vertraagde tijd Nasdaq  -  20/05 21:55:55 CEST
5.800 USD    0.00%
12/05FENNEC PHARMACEUTICALS INC. : Wedbush herhaalt koopadvies voor het aandeel
MM
12/05FENNEC PHARMACEUTICALS INC. : Wedbush ontvangt een koopadvies
MM
12/05Fennec Pharmaceuticals nettoverlies in het eerste kwartaal daalt
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiële publicatiesSectornieuws
Communiqués de presse de la société FENNEC PHARMACEUTICALS INC.
12/05FENNEC PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Conditio..
AQ
12/05Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Busi..
GL
28/04Fennec pharmaceuticals announces fda acceptance for filing of new drug application resu..
AQ
27/04Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resu..
GL
05/04FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t..
PR
29/03FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t..
PR
28/03Fennec pharmaceuticals to participate in the 2022 maxim virtual growth conference
AQ
25/03Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference
GL
24/03FENNEC PHARMACEUTICALS : RESUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINSTRATIO..
PU
24/03FENNEC PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
24/03Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administrat..
AQ
22/03FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t..
PR
15/03FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t..
PR
08/03FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t..
PR
01/03FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t..
PR
28/02FENNEC PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Conditio..
AQ
28/02Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Busine..
GL
15/02FENC ALERT : The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in t..
PR
14/02SHAREHOLDER ALERT : Robbins LLP Reminds Investors That Fennec Pharmaceuticals Inc. (FENC) ..
BU
11/02Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigati..
BU
11/02INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Fennec Pharmace..
BU
11/02SHAREHOLDER ALERT : Robbins LLP Informs Investors that Fennec Pharmaceuticals Inc. (FENC) ..
BU
11/02The Law Offices of Frank R. Cruz Announces Investigation of Fennec Pharmaceuticals Inc...
BU
10/02Bronstein, Gewirtz & Grossman, LLC Notifies Fennec Pharmaceuticals Inc. (FENC) Investor..
BU
10/02Bronstein, Gewirtz & Grossman, LLC Notifies Fennec Pharmaceuticals Inc. (FENC) Investor..
BU
31/01FENNEC PHARMACEUTICALS : ANNOUNCES MANAGEMENT CHANGE - Form 8-K
PU
31/01FENNEC PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Financial Statem..
AQ
31/01FENNEC PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Financial Stateme..
AQ
31/01Fennec Pharmaceuticals Announces Management Change
AQ
17/01FENNEC PHARMACEUTICALS : Corporate Presentation January 2022
PU
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fenne..
PR
2021FENNEC PHARMACEUTICALS : Receives Complete Response Letter from the FDA for its New Drug A..
PU
2021Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug ..
AQ
2021Fennec pharmaceuticals expects to receive complete response letter from the fda for its..
AQ
2021FENNEC PHARMACEUTICALS : Expects to Receive Complete Response Letter from the FDA for its ..
PU
2021FENNEC PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its..
GL
2021FENNEC PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Conditio..
AQ
2021Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Busi..
GL
2021Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Busi..
GL
2021FENNEC PHARMACEUTICALS : to Participate in Upcoming Investor Conferences
AQ
2021FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
2021Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Bus..
GL
2021FENNEC PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders (form 8-..
AQ
2021Fennec Announces Results of Annual Meeting
GL
2021FENNEC PHARMACEUTICALS : ANNOUNCES AMENDMENT TO INCREASE EXISTING SENIOR DEBT FACILITY (Fo..
PU
2021FENNEC PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Other Events, Fi..
AQ
2021Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
GL
2021FENNEC PHARMACEUTICALS : Announces FDA Acceptance of New Drug Application Resubmission for..
AQ
2021FENNEC PHARMACEUTICALS : ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION RESUBMISSION FOR..
PU
2021FENNEC PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021FENNEC PHARMACEUTICALS : Announces fda acceptance of new drug application resubmission for..
PU
2021Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission fo..
GL
2021FENNEC PHARMACEUTICALS : Resubmits new drug application to u.s. food and drug administrati..
AQ
2021FENNEC PHARMACEUTICALS : Resubmits New Drug Application to U.S. Food and Drug Administrati..
AQ
2021Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Busi..
GL
2021FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
2020Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Busi..
GL
2020Fennec Announces Issuance of U.S. Patent for PEDMARK™
GL
2020Law Offices of Howard G. Smith Continues Investigation of Fennec Pharmaceuticals Inc. (..
BU
2020THE LAW OFFICES OF FRANK R. CRUZ : Continues Its Investigation of Fennec Pharmaceuticals I..
BU
2020GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Continues Investigation..
BU
2020Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Fennec Pharma..
BU
2020FENNEC ALERT : Bragar Eagel & Squire, P.C. is Investigating Fennec Pharmaceuticals, Inc. o..
BU
2020INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claims Against ..
BU
2020GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation..
BU
2020THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Fennec Pharmaceuticals Inc. ..
BU
2020Law Offices of Howard G. Smith Announces Investigation of Fennec Pharmaceuticals Inc. (..
BU
2020INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Fen..
BU
2020Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
GL
2020Fennec Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Bus..
GL
2020Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
GL
2020Fennec Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Busi..
GL
2020Fennec Announces Exercise and Closing of Underwriters' Option to Purchase Additional Sh..
GL
2020Fennec Announces Closing of Public Offering
GL
1  2Volgende
Volgende evenement op FENNEC PHARMACEUTICALS INC.